TickerSpark Feed

nasdaq

Everything tagged "nasdaq" across the TickerSpark archives.

Inside the Columbus Circle Cap Corp. Iii IPO: Setup, Risks, and Verdict
IPOCCCT

Inside the Columbus Circle Cap Corp. Iii IPO: Setup, Risks, and Verdict

Columbus Circle Cap Corp. Iii (NASDAQ: CCCT) is expected to list on 2026-07-31, but the price range has not been disclosed yet. This is a SPAC, so the real question is not near-term revenue but whether the team can find a credible target before the clock runs out. The setup favors investors who want sponsor pedigree and a Europe/North America deal pipeline, while the main bear case is classic SPAC dilution and no target in hand.

Jul 31, 20266 MIN
Southern Cross Acquisition I Corp. Rights IPO: What Investors Need to Know
IPONCOOR

Southern Cross Acquisition I Corp. Rights IPO: What Investors Need to Know

Southern Cross Acquisition I Corp. Rights (NASDAQ: NCOOR) is expected to list on 2026-07-31, but the price range has not been disclosed yet. This is a SPAC rights offering tied to a blank-check company, so the key question is what kind of deal the sponsor can eventually bring to market. The setup favors investors who are comfortable with SPAC optionality; the main bear case is the usual one: no target, no operating business, and dilution risk.

Jul 31, 20266 MIN
The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

Daily market recap + weekly preview. One-click unsubscribe in every email.

Biotech Acquisition Company IPO Preview: Sponsor Expertise Meets SPAC Risk
IPOBIOT

Biotech Acquisition Company IPO Preview: Sponsor Expertise Meets SPAC Risk

Biotech Acquisition Company is expected to list on NASDAQ on 2026-07-24, but the price range has not been disclosed yet. This is a SPAC, so the real story is not current revenue — it is whether the sponsor can find and close a healthcare or biotech deal that the market will back. The setup favors target-selection upside, but shareholders should watch the trust structure, redemption risk, and the lack of operating business today.

Jul 24, 20265 MIN
On-Demand Research

Need research on a stock not covered here?

Generate AI research on any ticker — grades, price targets, and full analysis in minutes.

Open the Generator